RxDoctor Payments DataLook up a doctor →

Sam Mansour, MD

Ophthalmology · Warrenton, VANPI 1376506873

Payments from drug & device makers

$77,047in general payments, 2019–2025

Across 142 payments — averaging $542.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Iridex Corporation$38K
  • Astellas Pharma Global Development$18K
  • ANI Pharmaceuticals, Inc.$6K
  • Eyepoint US, Inc.$5K
  • Alimera Sciences, Inc.$5K
  • Onmark, Inc.$2K
  • plus $4K from 24 others
$18,672in research payments, 2019–2025

Across 6 payments — averaging $3112.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alimera Sciences, Inc.$19K

What the payments were for

  • Consulting fees$37,65076%
  • Speaking & faculty fees$3,4367%
  • Travel & lodging$3,3137%
  • Food & beverage$5,00910%
  • Gifts$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,047 in reported general payments places this provider in the 95th percentile of 509 ophthalmology providers in Virginia.

See all ophthalmology providers in Virginia

Medicare billing

Part B allowed, 2024
$2,028,369
Medicare patients
1,225
Services billed
24,477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate106$4,384
Brimonidine Tartrate28$2,073
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14$1,857
Ketorolac Tromethamine63$1,643
Latanoprost98$1,181
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat56$1,082
Ofloxacin30$527
ErythromycinErythromycin Base30$309
Timolol Maleate24$181
Dorzolamide Hcl25$78

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Warrenton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →